Prednisone Terminated Phase 4 Trials for Disseminated Sclerosis Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01411514Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple Sclerosis